Cargando…

Epimacular brachytherapy for wet AMD: current perspectives

Age-related macular degeneration (AMD) is considered the most common cause of blindness in the over-60 age group in developed countries. There are basically two forms of presentation: geographic (dry or atrophic) and wet (neovascular or exudative). Geographic atrophy accounts for approximately 85%–9...

Descripción completa

Detalles Bibliográficos
Autores principales:	Casaroli-Marano, Ricardo P, Alforja, Socorro, Giralt, Joan, Farah, Michel E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155998/ https://www.ncbi.nlm.nih.gov/pubmed/25210436 http://dx.doi.org/10.2147/OPTH.S46068

Ejemplares similares

Post-perforation epimacular membrane: Do's and don'ts
por: Shukla, Dhananjay
Publicado: (2014)

Aflibercept in wet AMD: specific role and optimal use
por: Semeraro, F, et al.
Publicado: (2013)

Anti-VEGF Treatment Strategies for Wet AMD
por: Kovach, Jaclyn L., et al.
Publicado: (2012)

Artificial intelligence-based detection of epimacular membrane from color fundus photographs
por: Shao, Enhua, et al.
Publicado: (2021)

Structural and Functional Outcomes of Surgery for Lamellar Macular Holes with or without Epimacular Proliferations
por: Venkatesh, Ramesh, et al.
Publicado: (2022)

Current barriers to treatment for wet age-related macular degeneration (wAMD): findings from the wAMD patient and caregiver survey
por: Varano, Monica, et al.
Publicado: (2015)

Improving treatment provision of Wet AMD with intravitreal ranibizumab
por: Ghazala, Fadi, et al.
Publicado: (2013)

Aqueous humor cytokine profiling in patients with wet AMD
por: Liu, Fang, et al.
Publicado: (2016)

The MDM2 Single-Nucleotide Polymorphism T309G Is Associated With the Development of Epimacular Membranes
por: Jiang, Heng, et al.
Publicado: (2022)

Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2‐year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry
por: Gabrielle, Pierre‐Henry, et al.
Publicado: (2021)

Aflibercept in wet AMD beyond the first year of treatment: recommendations by an expert roundtable panel
por: McKibbin, M, et al.
Publicado: (2015)

Expression of VEGFA‐regulating miRNAs and mortality in wet AMD
por: Blasiak, Janusz, et al.
Publicado: (2019)

Diagnostic Odyssey in an Adult Patient with Ophthalmologic Abnormalities and Hearing Loss: Contribution of RNA-Seq to the Diagnosis of a PEX1 Deficiency
por: Muñoz-Pujol, Gerard, et al.
Publicado: (2022)

Ranibizumab for the treatment of wet AMD: a summary of real-world studies
por: Chong, V
Publicado: (2016)

Aflibercept in refractory wet AMD treated with ranibizumab: Anatomical and visual outcome
por: Abou-Ltaif, Sleiman
Publicado: (2016)

Surgical outcomes of macular hole and epimacular membrane treatment in patients with intraoperative amaurosis under sub-Tenon’s anesthesia
por: Zhang, Qi, et al.
Publicado: (2020)

Two Year Study of Aflibercept and Ranibizumab Intravitreal Therapy in Patients with Wet AMD
por: Luksa, Dorota, et al.
Publicado: (2021)

Stereotactic radiotherapy for wet age-related macular degeneration: current perspectives
por: Neffendorf, James E, et al.
Publicado: (2015)

PGE(2) promotes macrophage recruitment and neovascularization in murine wet-type AMD models
por: Zhan, Pengfei, et al.
Publicado: (2022)

Single-Cell Transcriptome of Wet AMD Patient-Derived Endothelial Cells in Angiogenic Sprouting
por: Yeo, Natalie Jia Ying, et al.
Publicado: (2022)

Current Concepts on Subtalar Instability
por: Pereira, Bruno S., et al.
Publicado: (2021)

Reliability of Intraocular Pressure Measurement by Goldmann Applanation Tonometry After Refractive Surgery: A Review of Different Correction Formulas [Letter]
por: Iglesias, María, et al.
Publicado: (2021)

Assessment of macular function, structure and predictive value of pattern electroretinogram parameters for postoperative visual acuity in patients with idiopathic epimacular membrane
por: Lubiński, Wojciech, et al.
Publicado: (2016)

Novel Association of High C-Reactive Protein Levels and A69S at Risk Alleles in Wet Age-Related Macular Degeneration Women
por: Fernandez-Robredo, Patricia, et al.
Publicado: (2018)

Short-term outcomes of switching anti-VEGF agents in eyes with treatment-resistant wet AMD
por: Batioglu, Figen, et al.
Publicado: (2015)

Development of an inducible anti-VEGF rAAV gene therapy strategy for the treatment of wet AMD
por: Reid, Christopher A., et al.
Publicado: (2018)

Scleral Fixation of Posteriorly Dislocated Intraocular Lenses by 23-Gauge Vitrectomy without Anterior Segment Approach
por: Nadal, Jeroni, et al.
Publicado: (2015)

The Role of Mitochondria in AMD: Current Knowledge and Future Applications
por: Riazi-Esfahani, Mohammad, et al.
Publicado: (2017)

Gains in the current understanding of managing neovascular AMD with brolucizumab
por: Bodaghi, Bahram, et al.
Publicado: (2023)

Perspective on AMD Pathobiology: A Bioenergetic Crisis in the RPE
por: Fisher, Cody R., et al.
Publicado: (2018)

Elusive drusen and changing terminology of AMD
por: De Jong, P. T. V. M.
Publicado: (2018)

Matrix Metalloproteinases in Age-Related Macular Degeneration (AMD)
por: García-Onrubia, Luis, et al.
Publicado: (2020)

Understanding AMD by analogy: systematic review of lipid-related common pathogenic mechanisms in AMD, AD, AS and GN
por: Xu, Qinyuan, et al.
Publicado: (2018)

Current Status of Brachytherapy for Prostate Cancer
por: Park, Dong Soo
Publicado: (2012)

The emotional and physical impact of wet age-related macular degeneration: findings from the wAMD Patient and Caregiver Survey
por: Varano, Monica, et al.
Publicado: (2016)

Bevacizumab in Wet AMD treatment: A tribute to the thirteen years of experience from the beginning of the anti-VEGF era in Romania
por: Stanca, Horia T., et al.
Publicado: (2019)

FUSION regimen: ranibizumab in treatment-naïve patients with exudative age-related macular degeneration and relatively good baseline visual acuity
por: Monés, Jordi, et al.
Publicado: (2012)

NLRP3 Inflammasome and Pathobiology in AMD
por: Celkova, Lucia, et al.
Publicado: (2015)

Potential Role of Induced Pluripotent Stem Cells (IPSCs) for Cell-Based Therapy of the Ocular Surface
por: Casaroli-Marano, Ricardo P., et al.
Publicado: (2015)

Limbal Stem Cells from Aged Donors Are a Suitable Source for Clinical Application
por: Nieto-Nicolau, Nuria, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_d3bte4729vchfc9fu46av38119